Medication-induced hyperlipoproteinemia is a condition that results from the decreasing of lipoprotein lipase activity resulting in eruptive xanthomas.

See also Normolipoproteinemic xanthomatosis Cerebrotendinous xanthomatosis Skin lesion

References